METOPROLOL

Generic: METOPROLOL

Manufacturer: Alembic Pharmaceuticals Inc.

Nonsteroidal Anti-inflammatory Drug [EPC]Platelet Aggregation Inhibitor [EPC]Loop Diuretic [EPC]HMG-CoA Reductase Inhibitor [EPC]Corticosteroid [EPC]
246,257
Total Reports
81,660
Serious Reports
27,933
Death Reports
30
Reported Reactions
Death Report Ratio: High (11.34%)

Patient Demographics

Male
107,699
Female
122,553

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for METOPROLOL.

# Reaction Reports % of Total
1 FATIGUE 15,965
6.5%
2 DYSPNOEA 14,133
5.7%
3 DIARRHOEA 13,635
5.5%
4 NAUSEA 13,396
5.4%
5 DRUG INEFFECTIVE 12,521
5.1%
6 DIZZINESS 11,704
4.7%
7 OFF LABEL USE 9,793
4.0%
8 DEATH 9,737
3.9%
9 ASTHENIA 9,413
3.8%
10 PAIN 9,112
3.7%
11 FALL 9,086
3.7%
12 HEADACHE 8,840
3.6%
13 HYPOTENSION 7,535
3.0%
14 VOMITING 7,129
2.9%
15 PNEUMONIA 7,103
2.9%
16 ARTHRALGIA 6,783
2.7%
17 ATRIAL FIBRILLATION 6,690
2.7%
18 WEIGHT DECREASED 6,450
2.6%
19 ACUTE KIDNEY INJURY 6,382
2.6%
20 MALAISE 6,377
2.6%
21 HYPERTENSION 6,049
2.4%
22 COUGH 5,981
2.4%
23 PAIN IN EXTREMITY 5,885
2.4%
24 MYOCARDIAL INFARCTION 5,870
2.4%
25 RENAL FAILURE 5,542
2.2%
26 RASH 5,412
2.2%
27 CHRONIC KIDNEY DISEASE 5,353
2.2%
28 PRURITUS 5,304
2.1%
29 DECREASED APPETITE 5,210
2.1%
30 CHEST PAIN 5,116
2.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.